Lack of association of the <it>CIITA </it>-168A→G promoter SNP with myasthenia gravis and its role in autoimmunity
<p>Abstract</p> <p>Background</p> <p>The major histocompatibility complex class II transactivator (CIITA) regulates MHC class II gene expression. A promoter SNP -168A→G (rs3087456) has previously been shown to be associated with susceptibility to several immune mediated...
Main Authors: | Hammarström Lennart, Pirskanen Ritva, Zhao Yaofeng, Ramanujam Ryan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-10-01
|
Series: | BMC Medical Genetics |
Online Access: | http://www.biomedcentral.com/1471-2350/11/147 |
Similar Items
-
The CD45 77C/G allele is not associated with myasthenia gravis - a reassessment of the potential role of CD45 in autoimmunity
by: Hammarström Lennart, et al.
Published: (2010-11-01) -
Treatment of Autoimmune Myasthenia Gravis
by: J Gordon Millichap
Published: (2004-02-01) -
Autoimmune Thyroiditis and Myasthenia Gravis
by: Angela Lopomo, et al.
Published: (2017-07-01) -
Advances in Autoimmune Myasthenia Gravis
Published: (2020) -
Editorial: Advances in Autoimmune Myasthenia Gravis
by: Anna Rostedt Punga, et al.
Published: (2020-08-01)